These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 686773

  • 1. Reduction of bile acid loss in cystic fibrosis by dietary means.
    Smalley CA, Brown GA, Parkes ME, Tease H, Brookes V, Anderson CM.
    Arch Dis Child; 1978 Jun; 53(6):477-82. PubMed ID: 686773
    [Abstract] [Full Text] [Related]

  • 2. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL, Fine DR, Batten JC, Northfield TC.
    Gut; 1985 Sep; 26(9):892-901. PubMed ID: 3849459
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL, Fitzpatrick WJ, Batten JC, Northfield TC.
    Gut; 1984 May; 25(5):500-7. PubMed ID: 6714794
    [Abstract] [Full Text] [Related]

  • 6. Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency.
    Roller RJ, Kern F.
    Gastroenterology; 1977 Apr; 72(4 Pt 1):661-5. PubMed ID: 838220
    [Abstract] [Full Text] [Related]

  • 7. Malabsorption of bile acids in children with cystic fibrosis.
    Weber AM, Roy CC, Morin CL, Lasalle R.
    N Engl J Med; 1973 Nov 08; 289(19):1001-5. PubMed ID: 4742200
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ, Long WB, Balistreri WF, Widzer SJ, Huang N.
    Gastroenterology; 1980 May 08; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of dietary fat and residues on fecal loss of sterols and on their microbial degradation in cystic fibrosis.
    Leroy C, Lepage G, Morin CL, Bertrand JM, Dufour-Larue O, Roy CC.
    Dig Dis Sci; 1986 Sep 08; 31(9):911-8. PubMed ID: 3089744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Total faecal bile acid excretion in children.
    Leyland C.
    Arch Dis Child; 1970 Oct 08; 45(243):714. PubMed ID: 5477700
    [No Abstract] [Full Text] [Related]

  • 17. Clinical monitoring of steatorrhoea in cystic fibrosis.
    Walters MP, Kelleher J, Gilbert J, Littlewood JM.
    Arch Dis Child; 1990 Jan 08; 65(1):99-102. PubMed ID: 2301990
    [Abstract] [Full Text] [Related]

  • 18. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.
    Robb TA, Davidson GP, Kirubakaran C.
    Gut; 1985 Nov 08; 26(11):1246-56. PubMed ID: 4065698
    [Abstract] [Full Text] [Related]

  • 19. [Long-term use of medium chain triglycerides in cystic fibrosis (author's transl)].
    Widhalm K, Götz M.
    Wien Klin Wochenschr; 1976 Sep 17; 88(17):557-61. PubMed ID: 997539
    [Abstract] [Full Text] [Related]

  • 20. The influence of long-term cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis.
    Chalmers DM, Brown RC, Miller MG, Clarke PC, Kelleher J, Littlewood JM, Losowsky MS.
    Acta Paediatr Scand; 1985 Jan 17; 74(1):114-7. PubMed ID: 3885675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.